Topic

UnitedHealthcare (UnitedHealth Group)

A collection of 1056 issues

How to Get Cabometyx (Cabozantinib) Covered by UnitedHealthcare in Washington: Complete PA Guide with ICD-10 Codes and Appeals

Answer Box: Getting Cabometyx Covered by UnitedHealthcare in Washington UnitedHealthcare requires prior authorization (PA) for Cabometyx (cabozantinib tablets) through OptumRx for all FDA-approved cancer indications in Washington. Submit PA with confirmed diagnosis (ICD-10: C64 for RCC, C22.0 for HCC), prior therapy documentation, and RECIST imaging showing progression. If denied,
6 min read

Getting Mycapssa (Octreotide Oral) Approved by UnitedHealthcare in Georgia: Prior Authorization Guide and Appeals Process

Answer Box: How to Get Mycapssa Approved by UnitedHealthcare in Georgia UnitedHealthcare requires prior authorization for Mycapssa (oral octreotide) with step therapy mandating prior response to injectable octreotide or lanreotide. Submit your PA through OptumRx with acromegaly diagnosis (E22.0), documented injectable response, and medical necessity letter. If denied, you
5 min read

How to Get Kymriah (tisagenlecleucel) Covered by UnitedHealthcare in Virginia: Complete Prior Authorization and Appeals Guide

Answer Box: Getting Kymriah Covered by UnitedHealthcare in Virginia UnitedHealthcare covers Kymriah (tisagenlecleucel) under medical benefits as autologous stem cell therapy, requiring prior authorization through OptumHealth Transplant Solutions. For B-cell ALL (≤25 years) or relapsed/refractory DLBCL after ≥2 therapy lines, submit via the UHC Provider Portal with CD19+ confirmation,
6 min read

Lowering Out-of-Pocket Costs for Enhertu with UnitedHealthcare in North Carolina: Copay Cards, Tiering Appeals, and Financial Assistance

Answer Box: Enhertu (fam-trastuzumab deruxtecan-nxki) costs $150,000+ annually but UnitedHealthcare commercial patients can reduce out-of-pocket to $0 drug cost plus $100/infusion using the ENHERTU4U copay program. Submit prior authorization via UnitedHealthcare Provider Portal with HER2-positive pathology results and prior therapy documentation. If denied, appeal internally within 180 days,
6 min read

How to Get Givlaari (Givosiran) Covered by UnitedHealthcare in Washington: Complete Prior Authorization and Appeals Guide

Answer Box: Getting Givlaari Covered by UnitedHealthcare in Washington Givlaari (givosiran) requires prior authorization from UnitedHealthcare OptumRx, with potential step therapy requirements. Washington state law (RCW 48.43.420) provides strong protections for step therapy exceptions when medically necessary. First step: Have your specialist submit a prior authorization request with
6 min read

How to Get Amvuttra (Vutrisiran) Covered by UnitedHealthcare in Washington: Complete Guide to Prior Authorization, Appeals, and External Review

Answer Box: Getting Amvuttra Covered by UnitedHealthcare in Washington UnitedHealthcare requires prior authorization for Amvuttra (vutrisiran) in Washington. Submit documentation including TTR genetic testing, specialist evaluation, and baseline outcomes via OptumRx PreCheck Prior Authorization or call 1-800-711-4555. If denied, appeal within 65 days internally, then request external review through Washington&
6 min read

Work With Your Doctor to Get Opdivo (nivolumab) Approved by UnitedHealthcare in Ohio: Complete Provider Collaboration Guide

Answer Box: Your Path to Opdivo Approval Getting Opdivo (nivolumab) covered by UnitedHealthcare in Ohio requires prior authorization with specific biomarker testing and clinical documentation. Work with your oncologist to submit evidence through UnitedHealthcare's provider portal, request peer-to-peer review if denied (~85% overturn rate), and use Ohio'
6 min read

Myths vs. Facts: Getting Uplizna (Inebilizumab) Covered by UnitedHealthcare in California

Quick Answer: UnitedHealthcare requires prior authorization for Uplizna (inebilizumab) in California with specific documentation: AQP4-positive NMOSD diagnosis, neurologist prescription, HBV screening, and often step therapy with eculizumab first. If denied, file internal appeal within 180 days, then California's Independent Medical Review (IMR) through DMHC. Start by gathering AQP4-IgG
5 min read